E Fund Management’s Zimmer Biomet ZBH Stock Holding History

E Fund Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$345K	Sell	4,008 -41	-1%	-$3.6K	0.01%	359
2026 Q1	$366K	Buy	+4,049	New	+$372K	0.01%	347
2025 Q2	$298K	Sell	3,265 -29	-0.9%	-$2.8K	0.01%	308
2025 Q1	$373K	Sell	3,294 -236	-7%	-$25.2K	0.02%	259
2024 Q4	$373K	Buy	3,530 +1,508	+75%	+$162K	0.02%	269
2024 Q3	$218K	Buy	2,022 +105	+5%	+$11.5K	0.01%	309
2024 Q2	$208K	Buy	1,917 +189	+11%	+$22.3K	0.01%	283
2024 Q1	$228K	Buy	+1,728	New	+$216K	0.01%	318
2021 Q4	–	Sell	-1,410	Closed	-$201K	–	312
2021 Q3	$201K	Buy	+1,410	New	+$207K	0.01%	233

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

E Fund Management's ZBH Position: Q2 2026 in Review

E Fund Management reduced its Zimmer Biomet (ZBH) stake by 1% in Q2 2026, selling an estimated $3.6K and leaving 4,008 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #359.

E Fund Management first reported a position in ZBH in Q3 2021 and has held it in 9 quarters since. The position peaked at $373K in Q4 2024. 908 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

E Fund Management held 4,008 shares of Zimmer Biomet worth $345K as of Q2 2026.
E Fund Management sold 41 Zimmer Biomet shares in Q2 2026, an estimated $3.6K.
Zimmer Biomet made up 0.01% of E Fund Management's portfolio in Q2 2026, its #359 holding.
E Fund Management first reported a position in Zimmer Biomet in Q3 2021 and has held it in 9 quarters since.
E Fund Management's Zimmer Biomet position peaked at $373K in Q4 2024.
908 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.